Leadership
Recommendations to mitigate attrition among clinical research and drug manufacturing investigators at the FDA have not been implemented, and a Strategic Workforce Plan aimed at addressing recruiting, retention and training challenges has been shelved, the Government Accountability Office said.
Umbrella branding in OTC medicines supports responsible self‑care by helping consumers navigate choices, build trust and confidence, and access reliable health information, countering regulators’ long‑standing focus on risks rather than benefits, says PAGB CEO Michelle Riddalls.
A round-up of the latest European people moves: Angelini hires external affairs chief; Pierre Fabre appoints impact and reputation officer; Boots changes leadership at the top.
HBW Insight speaks to ex-Perrigo ESG expert Steve Ramus about the state of sustainability in consumer health and where we might be heading in the near future. Part one of two.
Industry associations in the UK, Germany and Greece expect 2026 to be the year self‑care policy is translated into day‑to‑day system change. They highlight opportunities in pharmacy, digital tools and regulatory reform, but warn that progress depends on political timing and regulatory agility.
A round-up of the latest European people moves: Dr C. Soldan names new managing directors; EU Specialty Food Ingredients changes secretary general; ASA gets independent reviewer.
GSCF, AESGP and ILAR agree that 2026 will see self‑care translate into more tangible system‑level action, propelled by prevention, regulatory updates and more assertive efforts to counter misleading claims.
Round up of latest European health & wellness people moves: Angelini Pharma gets new CEO; Stada names government affairs chief; NèreS adds to board.
While it's not clear that it will, if the tech bubble bursts, innovation and investment in consumer health could slow, according to Euromonitor 's Magda Starula. Meanwhile, climate change is reshaping allergy and respiratory needs, creating opportunities for industry.
Executives from Opella, Haleon, Bayer, Kenvue, Cooper and Maxwellia anticipate a year of rapid growth in self‑care and personalised health, driven by digital tools, smarter OTC access and evidence‑led innovation across Europe and beyond.
A round-up of the latest health & wellness people moves: Haleon adds chief growth officer role; DSM-Firmenich names HR chief; SkinBioTherapeutics makes additions to its board.
Round up of latest European people moves: Karo makes additions to corporate team; Haleon names Portugal head; Pharma Deutschland adds experience.
A round up of the latest European health and wellness people moves: Enzymatica names acting CFO; Sandoz has new head of OTC Europe; Dr. Pfleger adds managing director.
A round-up of the latest people moves: Stada names general counsel; Nestlé announces departures; CMA elects board members.
“In the coming years, growth will depend on whether brands can combine trust, personalization, and proof of evidence into one coherent prevention experience,” argue Simon Kucher's Clemens Oberhammer and Christian Rebholz in this exclusive interview.
In another surprise leadership move, Commissioner Martin Makary named Høeg, who has stirred controversy with her involvement in FDA vaccine issues, the interim replacement for Richard Pazdur.
FDA says Teresa Michele, in CDER nonprescription drugs program leadership roles since 2013, was being moved to another position in the agency.
Pazdur’s departure just weeks into the job creates more uncertainty for the biopharma industry and an embarrassing situation for Commissioner Martin Makary, who personally lobbied him to take the position.
A round up of the latest people moves in Europe: ANEFP names president; Pharma Deutschland makes board changes; Salus shakes up management.
FDA leadership drama continues after Richard Pazdur was elevated to drug center director. Can Pazdur, CBER Director Vinay Prasad and Commissioner Martin Makary get along?